Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2

Emerging variants of SARS-CoV-2 call for frequent changes in vaccine antigens. Nucleic acid-based vaccination strategies are superior as the coding sequences can be easily altered with little impact on downstream production. mRNA vaccines, including variant-specific boosters, are approved for SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Neeli, Praveen, Chai, Dafei, Wang, Xu, Sobhani, Navid, Udeani, George, Li, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10271916/
https://www.ncbi.nlm.nih.gov/pubmed/37361876
http://dx.doi.org/10.1016/j.isci.2023.107120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10271916/
https://www.ncbi.nlm.nih.gov/pubmed/37361876
http://dx.doi.org/10.1016/j.isci.2023.107120

Ejemplares similares